{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":23,"n_cols":5,"rows_kept":23,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[7,2,7,3],[8,2,8,3],[10,2,10,3],[13,2,13,3],[14,2,14,3],[18,2,18,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910143686403321"]
[null,null,"Titolo",null,"Severe dementia / / editors, Alistair Burns, Bengt Winblad"]
[null,null,"Pubbl/distr/stampa",null,"Chichester, West Sussex, England ; ; Hoboken, NJ, : John Wiley & Sons, c2006"]
[null,null,"ISBN",null,"1-280-45054-1"]
[{"$nulls":4},"9786610450541"]
[{"$nulls":4},"0-470-01056-8"]
[{"$nulls":4},"0-470-01055-X"]
[null,null,"Descrizione fisica",null,"1 online resource (262 p.)"]
[null,null,"Disciplina",null,"616.83"]
[{"$nulls":4},"616.831061"]
[null,null,"Soggetti",null,"Dementia"]
[{"$nulls":4},"Dementia - Chemotherapy"]
[{"$nulls":4},"Dementia - Treatment"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Severe Dementia; Contents; List of Contributors; Introduction; Part 1 Introductory; Chapter 1 Assessment and Diagnosis of Severe Dementia; Chapter 2 Cholinergic and Serotonergic Systems in Severe Dementia; Chapter 3 The Molecular Pathology of Severe Dementia; Part 2 Clinical Features of Severe Dementia; Chapter 4 Cognitive Functions in Severe Dementia; Chapter 5 Behavioural and Psychological Symptoms of Dementia - Agitation; Chapter 6 Depression in Severe Dementia; Chapter 7 Physical Aspects of Severe Alzheimer's Disease; Chapter 8 Clinical Features of Severe Dementia: Staging"]
[{"$nulls":4},"Chapter 9 Clinical Features of Severe Dementia: FunctionPart 3 Management; Chapter 10 Drug Treatment: Memantine; Chapter 11 Drug Treatment: Cholinesterase Inhibitors; Chapter 12 Drug Treatment: Treatment of Behavioural and Psychological Symptoms of Dementia with Neuroleptics; Chapter 13 Non-pharmacological Treatment of Severe Dementia: An Overview; Chapter 14 Non-pharmacological Treatment of Severe Dementia:the Seattle Protocols; Chapter 15 Care by Families for Late Stage Dementia; Chapter 16 Person-centred Care for People with Severe Dementia"]
[{"$nulls":4},"Chapter 17 Palliative Care in Patients with Severe DementiaChapter 18 Narrative Ethics and Ethical Narratives in Dementia; Chapter 19 Health "]
[{"$nulls":4},"Economics of Severe Dementia; Index"]
[null,null,null,"Sommario/riassunto","The later stages of dementia are as important, if not more so, as the earlier stages, since they harbour unique characteristics and events, which profoundly affect the lives of patients and their carers. Severe dementia has not had a high profile in the clinical literature as until recently prognosis was poor and there were few beneficial interventions. With the recent licensing of memantine, clinicians finally have a drug option that will delay disease progression.  Severe Dementia is the first book to focus exclusively on severe dementia. It addresses both the clinical featur"]